切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2023, Vol. 16 ›› Issue (06) : 488 -491. doi: 10.3877/cma.j.issn.1674-6880.2023.06.008

短篇论著

急性心肌梗死后心力衰竭患者血清微小RNA-200a表达及临床意义
卢凯(), 王香云   
  1. 313000 浙江湖州,湖州市第一人民医院心内科
    313000 浙江湖州,湖州市第一人民医院神经内科
  • 收稿日期:2023-03-05 出版日期:2023-12-31
  • 通信作者: 卢凯
  • 基金资助:
    浙江省医药卫生科技计划项目(2023KY320)

Expression of serum microRNA-200a in patients with heart failure after acute myocardial infarction and its clinical significance

Kai Lu(), Xiangyun Wang   

  • Received:2023-03-05 Published:2023-12-31
  • Corresponding author: Kai Lu
引用本文:

卢凯, 王香云. 急性心肌梗死后心力衰竭患者血清微小RNA-200a表达及临床意义[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(06): 488-491.

Kai Lu, Xiangyun Wang. Expression of serum microRNA-200a in patients with heart failure after acute myocardial infarction and its clinical significance[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(06): 488-491.

目的

通过检测血清微小RNA-200a(miR-200a)在急性心肌梗死(AMI)后心力衰竭患者血液循环中的改变,探讨其与AMI后心力衰竭的相关性。

方法

选取2018年1月至2020年12月在湖州市第一人民医院收住的60例AMI后心力衰竭患者为观察组,另选取50例无AMI体检者作为对照组。比较2组受试者的一般资料、脑钠肽(BNP)、左心室射血分数(LVEF)。采用实时荧光定量PCR法检测2组受试者血清miR-200a的相对表达量,并分析血清miR-200a水平与AMI后心力衰竭的相关性。采用受试者工作特征(ROC)曲线分析miR-200a水平对AMI后心力衰竭的预测价值。

结果

观察组患者血清miR-200a表达水平[(15.1 ± 3.8)vs.(5.1 ± 1.6),t = 22.143,P = 0.004]及BNP水平[(621 ± 58)ng/L vs.(15 ± 4)ng/L,t = 40.125,P = 0.014]均较对照组显著升高,LVEF水平[(48.4 ± 4.8)% vs.(58.4 ± 2.6)%,t = 2.141,P = 0.035]较对照组显著降低。Pearson相关分析发现miR-200a表达水平与BNP呈正相关(r = 0.645,P = 0.023),而与LVEF呈负相关(r = -0.653,P = 0.044)。ROC曲线分析结果显示,miR-200a预测AMI后心力衰竭的曲线下面积为0.875,95%置信区间为(0.813,0.936),敏感度和特异度分别为0.825、0.842(P = 0.011)。

结论

AMI后心力衰竭患者血清miR-200a水平显著升高,对预测AMI后心力衰竭具有较高的敏感度和特异度。

表1 2组受试者一般资料比较( ± s
图1 miR-200a预测AMI后心力衰竭的ROC曲线分析注:miR-200a.微小RNA-200a;AMI.急性心肌梗死;ROC.受试者工作特征
1
Mansour SM, El-Abhar HS, Soubh AA. MiR-200a inversely correlates with Hedgehog and TGF-β canonical/non-canonical trajectories to orchestrate the anti-fibrotic effect of Tadalafil in a bleomycin-induced pulmonary fibrosis model[J]. Inflammopharmacology, 2021, 29 (1): 167-182.
2
Ye M, Wang S, Sun P, Qie J. Integrated microRNA expression profile reveals dysregulated miR-20a-5p and miR-200a-3p in liver fibrosis[J]. Biomed Res Int, 2021: 9583932.
3
Yu Y, Bai F, Qin N, et al. Non-proximal renal tubule-derived urinary exosomal miR-200b as a biomarker of renal fibrosis[J]. Nephron, 2018, 139 (3): 269-282.
4
中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志2019,47(10):766-783.
5
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018)[J]. J Am Coll Cardiol, 2018, 72 (18): 2231-2264.
6
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart J. 2021 Oct 14] [J]. Eur Heart J, 2021, 42 (36): 3599-3726.
7
Zhang Z, Xu L, He L, et al. MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer[J]. J Cancer, 2020, 11 (13): 3771-3782.
8
Wei J, Yang L, Wu YN, et al. Serum miR-1290 and miR-1246 as potential diagnostic biomarkers of human pancreatic cancer[J]. J Cancer, 2020, 11 (6): 1325-1333.
9
Dong Y, Zhang N, Zhao S, et al. miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer[J]. Oncol Lett, 2019, 18 (6): 6491-6500.
10
Wei Z, Chang K, Fan C, et al. MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1[J]. Cancer Cell Int, 2020 (20): 82.
11
Tran KV, Tanriverdi K, Aurigemma GP, et al. Circulating extracellular RNAs, myocardial remodeling, and heart failure in patients with acute coronary syndrome[J]. J Clin Transl Res, 2019, 5 (1): 33-43.
12
Zhong Z, Wu H, Zhong W, et al. Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction[J]. J Clin Lab Anal, 2020, 34 (3): e23099.
13
Chen Z, Li C, Lin K, et al. MicroRNAs in acute myocardial infarction: evident value as novel biomarkers?[J]. Anatol J Cardiol, 2018, 19 (2): 140-147.
14
Wang Q, Ma J, Jiang Z, et al. Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2017, 96 (24): e7173.
15
Fu Q, Pan H, Tang Y, et al. MiR-200a-3p aggravates DOX-induced cardiotoxicity by targeting PEG3 through SIRT1/NF-κB signal pathway[J]. Cardiovasc Toxicol, 2021, 21 (4): 302-313.
16
Wang Y, Jiang Y, Sun X, et al. Downregulation of miR-200a protects cardiomyocyte against apoptosis[J]. Biomed Pharmacother, 2020 (123): 109303.
17
Yang T, Liu T, Cao C, Xu S. miR-200a-5p augments cardiomyocyte hypertrophy induced by glucose metabolism disorder via the regulation of selenoproteins[J]. J Cell Physiol, 2019, 234 (4): 4095-4103.
18
Tripathi R, Wang D, Sullivan R, et al. Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide/B-Type natriuretic peptide and heart failure development[J]. Hypertension, 2016, 67 (2): 362-367.
19
Wang YP, Wang JH, Wang XL, et al. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention[J]. J Cell Mol Med, 2017, 21 (11): 2677-2684.
[1] 薛艳玲, 马小静, 谢姝瑞, 何俊, 夏娟, 何亚峰. 左心声学造影在急性心肌梗死合并室间隔穿孔中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2023, 20(10): 1036-1039.
[2] 李颖, 潘绍卿, 丁明岩, 孙丹丹, 曲海波, 侯培培, 朱芳. 实时三维超声心动图对高度房室传导阻滞伴射血分数保留的心力衰竭患者左束支区域起搏后左心室功能及同步性的评价[J/OL]. 中华医学超声杂志(电子版), 2023, 20(04): 430-436.
[3] 王友芳, 李兴超, 刘清敏, 刘德彬, 刘松伍, 郭冬冬, 车峰远. 应激性高血糖指数对经皮冠状动脉介入术后急性心肌梗死患者发生主要不良心脑血管事件的预测价值[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(02): 124-129.
[4] 刘亮, 肖浩, 崔晓磊, 吕宝谱, 张睿, 郑拓康, 孟庆冰, 姚冬奇, 田英平, 高恒波. 急性心肌梗死合并心源性休克患者预后因素分析97例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 183-189.
[5] 张洪, 王宏宇. 神经酰胺与心脏和血管疾病关系的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(11): 1202-1205.
[6] 王震, 杨晓月, 苏康康, 王朝阳, 李少杰, 陈淑霞, 谷剑. β受体阻滞剂对心力衰竭合并房颤患者预后影响的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(04): 479-482.
[7] 林永俭, 谢雪花, 郝莉茹, 刘丽, 马英东. 优化急诊绿色通道对急性心肌梗死介入治疗患者救治时间的影响[J/OL]. 中华介入放射学电子杂志, 2024, 12(02): 185-189.
[8] 米娜瓦尔·阿不都克力木, 董吁钢, 刘晨, 薛睿聪. 氯苯唑酸治疗野生型转甲状腺素蛋白心脏淀粉样变一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 119-122.
[9] 李云峰, 周世强, 李飞. 心力衰竭器械治疗新进展[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 113-118.
[10] 夏天, 孙磊, 朱业, 陈福坤, 顾仁杰, 郁维, 顾翔. 心脏再同步治疗超反应因疫情封控丢失而经调整起搏参数重新获得一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(01): 51-53.
[11] 田欢, 吴艳凯, 宋波, 魏榕辰, 张艳, 李月戈, 武柏林. 基于心脏磁共振多模态特征评估急性心肌梗死患者预后[J/OL]. 中华心脏与心律电子杂志, 2024, 12(01): 17-25.
[12] 王雅, 邹花一阳, 孙伟. 心房分流术治疗心力衰竭的研究进展[J/OL]. 中华心脏与心律电子杂志, 2024, 12(01): 45-50.
[13] 孔倩文, 刘姗, 曾彩虹, 曾庆春. 有氧运动和抗阻运动对心力衰竭患者心率变异性影响的观察性研究[J/OL]. 中华心脏与心律电子杂志, 2023, 11(03): 160-164.
[14] 曹婧然, 董福强, 张立剑, 刘长乐, 张煜坤, 陈康寅. 老年冠心病患者的营养风险、肌少症和衰弱筛查分析[J/OL]. 中华老年病研究电子杂志, 2024, 11(02): 5-9.
[15] 郑屹, 刘莹, 张煜坤, 李广平, 陈康寅, 刘彤. 既往及新发心房颤动对急性心肌梗死患者远期卒中风险的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 406-417.
阅读次数
全文


摘要